{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:58:40Z","timestamp":1790272720954,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T00:00:00Z","timestamp":1519430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["25221306-00"],"award-info":[{"award-number":["25221306-00"]}]},{"name":"Challenging Exploratory Research"},{"DOI":"10.13039\/100009666","name":"The Salt Science Research Foundation","doi-asserted-by":"crossref","award":["1422"],"award-info":[{"award-number":["1422"]}],"id":[{"id":"10.13039\/100009666","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009666","name":"The Salt Science Research Foundation","doi-asserted-by":"crossref","award":["1629"],"award-info":[{"award-number":["1629"]}],"id":[{"id":"10.13039\/100009666","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10157-018-1544-8","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T02:06:58Z","timestamp":1519438018000},"page":"501-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus"],"prefix":"10.1007","volume":"22","author":[{"given":"Fumiaki","family":"Ando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,24]]},"reference":[{"issue":"3","key":"1544_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.7326\/0003-4819-144-3-200602070-00007","volume":"144","author":"JM Sands","year":"2006","unstructured":"Sands JM, Bichet DG, Physicians ACo, Society AP. Nephrogenic diabetes insipidus. Ann Intern Med. 2006;144(3):186\u201394.","journal-title":"Ann Intern Med"},{"issue":"Suppl 3","key":"1544_CR2","first-page":"S180","volume":"15","author":"G Mishra","year":"2011","unstructured":"Mishra G, Chandrashekhar SR. Management of diabetes insipidus in children. Indian J Endocrinol Metab. 2011;15(Suppl 3):S180\u20137.","journal-title":"Indian J Endocrinol Metab"},{"key":"1544_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1877-1173(09)89002-9","volume":"89","author":"DG Bichet","year":"2009","unstructured":"Bichet DG. V2R mutations and nephrogenic diabetes insipidus. Prog Mol Biol Transl Sci. 2009;89:15\u201329.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"1544_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1086\/323643","volume":"69","author":"M Kuwahara","year":"2001","unstructured":"Kuwahara M, Iwai K, Ooeda T, Igarashi T, Ogawa E, Katsushima Y, et al. Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus. Am J Hum Genet. 2001;69(4):738\u201348.","journal-title":"Am J Hum Genet"},{"issue":"38","key":"1544_CR5","doi-asserted-by":"publisher","first-page":"14217","DOI":"10.1073\/pnas.0602331103","volume":"103","author":"E Sohara","year":"2006","unstructured":"Sohara E, Rai T, Yang SS, Uchida K, Nitta K, Horita S, et al. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation. Proc Natl Acad Sci USA. 2006;103(38):14217\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1544_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/MNH.0b013e3283094eb1","volume":"17","author":"D Brown","year":"2008","unstructured":"Brown D, Hasler U, Nunes P, Bouley R, Lu HA. Phosphorylation events and the modulation of aquaporin 2 cell surface expression. Curr Opin Nephrol Hypertens. 2008;17(5):491\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"23","key":"1544_CR7","doi-asserted-by":"publisher","first-page":"14800","DOI":"10.1074\/jbc.272.23.14800","volume":"272","author":"K Fushimi","year":"1997","unstructured":"Fushimi K, Sasaki S, Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem. 1997;272(23):14800\u20134.","journal-title":"J Biol Chem"},{"issue":"3","key":"1544_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.bbrc.2017.06.162","volume":"490","author":"N Yui","year":"2017","unstructured":"Yui N, Ando F, Sasaki S, Uchida S. Ser-261 phospho-regulation is involved in pS256 and pS269-mediated aquaporin-2 apical translocation. Biochem Biophys Res Commun. 2017;490(3):1039\u201344.","journal-title":"Biochem Biophys Res Commun"},{"issue":"36","key":"1544_CR9","doi-asserted-by":"publisher","first-page":"24617","DOI":"10.1074\/jbc.M803074200","volume":"283","author":"JD Hoffert","year":"2008","unstructured":"Hoffert JD, Fenton RA, Moeller HB, Simons B, Tchapyjnikov D, McDill BW, et al. Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. J Biol Chem. 2008;283(36):24617\u201327.","journal-title":"J Biol Chem"},{"issue":"10","key":"1544_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrneph.2015.89","volume":"11","author":"D Bockenhauer","year":"2015","unstructured":"Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol. 2015;11(10):576 \u2013 88.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1544_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1083\/jcb.200709177","volume":"182","author":"Y Noda","year":"2008","unstructured":"Noda Y, Horikawa S, Kanda E, Yamashita M, Meng H, Eto K, et al. Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking. J Cell Biol. 2008;182(3):587\u2013601.","journal-title":"J Cell Biol"},{"issue":"2","key":"1544_CR12","doi-asserted-by":"publisher","first-page":"F525","DOI":"10.1152\/ajprenal.00448.2007","volume":"295","author":"Y Li","year":"2008","unstructured":"Li Y, Konings IB, Zhao J, Price LS, de Heer E, Deen PM. Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2. Am J Physiol Renal Physiol. 2008;295(2):F525\u201333.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"1544_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1745-7270.2008.00438.x","volume":"40","author":"X Cheng","year":"2008","unstructured":"Cheng X, Ji Z, Tsalkova T, Mei F. Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim Biophys Sin (Shanghai). 2008;40(7):651 \u2013 62.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"4","key":"1544_CR14","doi-asserted-by":"publisher","first-page":"F882","DOI":"10.1152\/ajprenal.00411.2005","volume":"291","author":"KP Yip","year":"2006","unstructured":"Yip KP. Epac-mediated Ca(2+) mobilization and exocytosis in inner medullary collecting duct. Am J Physiol Renal Physiol. 2006;291(4):F882\u201390.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"47","key":"1544_CR15","doi-asserted-by":"publisher","first-page":"36839","DOI":"10.1074\/jbc.M005552200","volume":"275","author":"CL Chou","year":"2000","unstructured":"Chou CL, Yip KP, Michea L, Kador K, Ferraris JD, Wade JB, et al. Regulation of aquaporin-2 trafficking by vasopressin in the renal collecting duct. Roles of ryanodine-sensitive Ca2+ stores and calmodulin. J Biol Chem. 2000;275(47):36839\u201346.","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"1544_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1113\/jphysiol.2006.119644","volume":"577","author":"GG Holz","year":"2006","unstructured":"Holz GG, Kang G, Harbeck M, Roe MW, Chepurny OG. Cell physiology of cAMP sensor Epac. J Physiol. 2006;577(Pt 1):5\u201315.","journal-title":"J Physiol"},{"issue":"Pt 3","key":"1544_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1113\/jphysiol.2001.012606","volume":"538","author":"KP Yip","year":"2002","unstructured":"Yip KP. Coupling of vasopressin-induced intracellular Ca2+ mobilization and apical exocytosis in perfused rat kidney collecting duct. J Physiol. 2002;538(Pt 3):891\u20139.","journal-title":"J Physiol"},{"issue":"2","key":"1544_CR18","doi-asserted-by":"publisher","first-page":"F540","DOI":"10.1152\/ajprenal.00544.2009","volume":"300","author":"KP Yip","year":"2011","unstructured":"Yip KP, Sham JS. Mechanisms of vasopressin-induced intracellular Ca2 + oscillations in rat inner medullary collecting duct. Am J Physiol Renal Physiol. 2011;300(2):F540\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"1544_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0962-8924(00)01800-6","volume":"10","author":"D Chin","year":"2000","unstructured":"Chin D, Means AR. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 2000;10(8):322\u20138.","journal-title":"Trends Cell Biol"},{"issue":"14","key":"1544_CR20","doi-asserted-by":"publisher","first-page":"13624","DOI":"10.1074\/jbc.M500040200","volume":"280","author":"JD Hoffert","year":"2005","unstructured":"Hoffert JD, Chou CL, Fenton RA, Knepper MA. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J Biol Chem. 2005;280(14):13624\u201330.","journal-title":"J Biol Chem"},{"issue":"5","key":"1544_CR21","doi-asserted-by":"publisher","first-page":"F958","DOI":"10.1152\/ajprenal.2001.281.5.F958","volume":"281","author":"I Jo","year":"2001","unstructured":"Jo I, Ward DT, Baum MA, Scott JD, Coghlan VM, Hammond TG, et al. AQP2 is a substrate for endogenous PP2B activity within an inner medullary AKAP-signaling complex. Am J Physiol Renal Physiol. 2001;281(5):F958\u201365.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1544_CR22","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/01.ASN.0000128076.91545.BB","volume":"15","author":"JL Gooch","year":"2004","unstructured":"Gooch JL, P\u00e8rgola PE, Guler RL, Abboud HE, Barnes JL. Differential expression of calcineurin A isoforms in the diabetic kidney. J Am Soc Nephrol. 2004;15(6):1421\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1544_CR23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.V105923","volume":"10","author":"M Bens","year":"1999","unstructured":"Bens M, Vallet V, Cluzeaud F, Pascual-Letallec L, Kahn A, Rafestin-Oblin ME, et al. Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol. 1999;10(5):923\u201334.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1544_CR24","doi-asserted-by":"publisher","first-page":"C1606","DOI":"10.1152\/ajpcell.00588.2005","volume":"292","author":"SZ Li","year":"2007","unstructured":"Li SZ, McDill BW, Kovach PA, Ding L, Go WY, Ho SN, et al. Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress. Am J Physiol Cell Physiol. 2007;292(5):C1606\u201316.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"Pt 12","key":"1544_CR25","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1242\/jcs.02971","volume":"119","author":"JL Gooch","year":"2006","unstructured":"Gooch JL, Guler RL, Barnes JL, Toro JJ. Loss of calcineurin Aalpha results in altered trafficking of AQP2 and in nephrogenic diabetes insipidus. J Cell Sci. 2006;119(Pt 12):2468\u201376.","journal-title":"J Cell Sci"},{"issue":"2","key":"1544_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1681\/ASN.2006060664","volume":"18","author":"SW Lim","year":"2007","unstructured":"Lim SW, Ahn KO, Sheen MR, Jeon US, Kim J, Yang CW, et al. Downregulation of renal sodium transporters and tonicity-responsive enhancer binding protein by long-term treatment with cyclosporin A. J Am Soc Nephrol. 2007;18(2):421\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"1544_CR27","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/sj.onc.1208370","volume":"24","author":"N Kremenevskaja","year":"2005","unstructured":"Kremenevskaja N, von Wasielewski R, Rao AS, Sch\u00f6fl C, Andersson T, Brabant G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene. 2005;24(13):2144\u201354.","journal-title":"Oncogene"},{"issue":"16","key":"1544_CR28","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1128\/MCB.02354-05","volume":"26","author":"J Dejmek","year":"2006","unstructured":"Dejmek J, S\u00e4fholm A, Kamp Nielsen C, Andersson T, Leandersson K. Wnt-5a\/Ca2+-induced NFAT activity is counteracted by Wnt-5a\/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells. Mol Cell Biol. 2006;26(16):6024\u201336.","journal-title":"Mol Cell Biol"},{"issue":"41","key":"1544_CR29","doi-asserted-by":"publisher","first-page":"30990","DOI":"10.1074\/jbc.M603603200","volume":"281","author":"L Ma","year":"2006","unstructured":"Ma L, Wang HY. Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt\/cGMP\/Ca2+ pathway. J Biol Chem. 2006;281(41):30990 \u2013 1001.","journal-title":"J Biol Chem"},{"issue":"5","key":"1544_CR30","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1074\/jbc.M508386200","volume":"281","author":"A S\u00e4fholm","year":"2006","unstructured":"S\u00e4fholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutreix BO, Andersson T. A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. J Biol Chem. 2006;281(5):2740\u20139.","journal-title":"J Biol Chem"},{"key":"1544_CR31","doi-asserted-by":"publisher","first-page":"13636","DOI":"10.1038\/ncomms13636","volume":"7","author":"F Ando","year":"2016","unstructured":"Ando F, Sohara E, Morimoto T, Yui N, Nomura N, Kikuchi E, et al. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway. Nat Commun. 2016;7:13636.","journal-title":"Nat Commun"},{"issue":"12","key":"1544_CR32","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.1074\/jbc.M111880200","volume":"277","author":"U Hasler","year":"2002","unstructured":"Hasler U, Mordasini D, Bens M, Bianchi M, Cluzeaud F, Rousselot M, et al. Long term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem. 2002;277(12):10379\u201386.","journal-title":"J Biol Chem"},{"issue":"24","key":"1544_CR33","doi-asserted-by":"publisher","first-page":"21639","DOI":"10.1074\/jbc.M212388200","volume":"278","author":"U Hasler","year":"2003","unstructured":"Hasler U, Mordasini D, Bianchi M, Vandewalle A, F\u00e9raille E, Martin PY. Dual influence of aldosterone on AQP2 expression in cultured renal collecting duct principal cells. J Biol Chem. 2003;278(24):21639\u201348.","journal-title":"J Biol Chem"},{"issue":"2","key":"1544_CR34","doi-asserted-by":"publisher","first-page":"F334","DOI":"10.1152\/ajprenal.00180.2004","volume":"288","author":"M Bustamante","year":"2005","unstructured":"Bustamante M, Hasler U, Kotova O, Chibalin AV, Mordasini D, Rousselot M, et al. Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells. Am J Physiol Renal Physiol. 2005;288(2):F334\u201344.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1544_CR35","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1681\/ASN.2004110930","volume":"16","author":"U Hasler","year":"2005","unstructured":"Hasler U, Vinciguerra M, Vandewalle A, Martin PY, F\u00e9raille E. Dual effects of hypertonicity on aquaporin-2 expression in cultured renal collecting duct principal cells. J Am Soc Nephrol. 2005;16(6):1571\u201382.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"1544_CR36","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.bbamem.2006.06.001","volume":"1758","author":"F Umenishi","year":"2006","unstructured":"Umenishi F, Narikiyo T, Vandewalle A, Schrier RW. cAMP regulates vasopressin-induced AQP2 expression via protein kinase A-independent pathway. Biochim Biophys Acta. 2006;1758(8):1100\u20135.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1544_CR37","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1681\/ASN.2008060648","volume":"20","author":"BW Balkom van","year":"2009","unstructured":"van Balkom BW, Boone M, Hendriks G, Kamsteeg EJ, Robben JH, Stronks HC, et al. LIP5 interacts with aquaporin 2 and facilitates its lysosomal degradation. J Am Soc Nephrol. 2009;20(5):990\u20131001.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1544_CR38","doi-asserted-by":"publisher","first-page":"F1255","DOI":"10.1152\/ajprenal.00469.2010","volume":"300","author":"C Li","year":"2011","unstructured":"Li C, Wang W, Rivard CJ, Lanaspa MA, Summer S, Schrier RW. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am J Physiol Renal Physiol. 2011;300(5):F1255\u201361.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"1544_CR39","doi-asserted-by":"publisher","first-page":"F761","DOI":"10.1152\/ajprenal.00247.2010","volume":"300","author":"M Boone","year":"2011","unstructured":"Boone M, Kortenoeven ML, Robben JH, Tamma G, Deen PM. Counteracting vasopressin-mediated water reabsorption by ATP, dopamine, and phorbol esters: mechanisms of action. Am J Physiol Renal Physiol. 2011;300(3):F761\u201371.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"15","key":"1544_CR40","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1074\/jbc.M110.207878","volume":"286","author":"ML Kortenoeven","year":"2011","unstructured":"Kortenoeven ML, van den Brand M, Wetzels JF, Deen PM. Hypotonicity-induced reduction of aquaporin-2 transcription in mpkCCD cells is independent of the tonicity responsive element, vasopressin, and cAMP. J Biol Chem. 2011;286(15):13002\u201310.","journal-title":"J Biol Chem"},{"issue":"11","key":"1544_CR41","doi-asserted-by":"publisher","first-page":"F1395","DOI":"10.1152\/ajprenal.00376.2011","volume":"302","author":"ML Kortenoeven","year":"2012","unstructured":"Kortenoeven ML, Trimpert C, van den Brand M, Li Y, Wetzels JF, Deen PM. In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac. Am J Physiol Renal Physiol. 2012;302(11):F1395\u2013401.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"1544_CR42","doi-asserted-by":"publisher","first-page":"C131","DOI":"10.1152\/ajpcell.00197.2011","volume":"302","author":"ML Kortenoeven","year":"2012","unstructured":"Kortenoeven ML, Schweer H, Cox R, Wetzels JF, Deen PM. Lithium reduces aquaporin-2 transcription independent of prostaglandins. Am J Physiol Cell Physiol. 2012;302(1):C131\u201340.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"1544_CR43","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbamem.2006.03.004","volume":"1758","author":"Y Noda","year":"2006","unstructured":"Noda Y, Sasaki S. Regulation of aquaporin-2 trafficking and its binding protein complex. Biochim Biophys Acta. 2006;1758(8):1117\u201325.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1544_CR44","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1172\/JCI39680","volume":"119","author":"JH Li","year":"2009","unstructured":"Li JH, Chou CL, Li B, Gavrilova O, Eisner C, Schnermann J, et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest. 2009;119(10):3115\u201326.","journal-title":"J Clin Invest"},{"issue":"1","key":"1544_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1681\/ASN.2009121267","volume":"22","author":"R Bouley","year":"2011","unstructured":"Bouley R, Lu HA, Nunes P, Da Silva N, McLaughlin M, Chen Y, et al. Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration. J Am Soc Nephrol. 2011;22(1):59\u201372.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1544_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ki.2014.10","volume":"86","author":"G Procino","year":"2014","unstructured":"Procino G, Milano S, Carmosino M, Barbieri C, Nicoletti MC, Li JH, et al. Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. Kidney Int. 2014;86(1):127\u201338.","journal-title":"Kidney Int"},{"issue":"7","key":"1544_CR47","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1128\/MCB.01088-06","volume":"27","author":"JY Chu","year":"2007","unstructured":"Chu JY, Chung SC, Lam AK, Tam S, Chung SK, Chow BK. Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption. Mol Cell Biol. 2007;27(7):2499\u2013511.","journal-title":"Mol Cell Biol"},{"issue":"31","key":"1544_CR48","doi-asserted-by":"publisher","first-page":"12949","DOI":"10.1073\/pnas.1104691108","volume":"108","author":"ET Olesen","year":"2011","unstructured":"Olesen ET, R\u00fctzler MR, Moeller HB, Praetorius HA, Fenton RA. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc Natl Acad Sci USA. 2011;108(31):12949\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"1544_CR49","doi-asserted-by":"publisher","first-page":"8397","DOI":"10.1073\/pnas.1509565112","volume":"112","author":"M Gao","year":"2015","unstructured":"Gao M, Cao R, Du S, Jia X, Zheng S, Huang S, et al. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts. Proc Natl Acad Sci USA. 2015;112(27):8397\u2013402.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1544_CR50","doi-asserted-by":"publisher","first-page":"F935","DOI":"10.1152\/ajprenal.00559.2015","volume":"311","author":"ET Olesen","year":"2016","unstructured":"Olesen ET, Moeller HB, Assentoft M, MacAulay N, Fenton RA. The vasopressin type 2 receptor and prostaglandin receptors EP2 and EP4 can increase aquaporin-2 plasma membrane targeting through a cAMP-independent pathway. Am J Physiol Renal Physiol. 2016;311(5):F935\u201344.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"1544_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","volume":"119","author":"JY Park","year":"2006","unstructured":"Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol. 2006;119(3):229\u201340.","journal-title":"Clin Immunol"},{"issue":"2","key":"1544_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1681\/ASN.2012020217","volume":"24","author":"ET Olesen","year":"2013","unstructured":"Olesen ET, Fenton RA. Is there a role for PGE2 in urinary concentration? J Am Soc Nephrol. 2013;24(2):169\u201378.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1544_CR53","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/CIRCULATIONAHA.108.191627","volume":"119","author":"WS Harris","year":"2009","unstructured":"Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119(6):902\u20137.","journal-title":"Circulation"},{"issue":"1","key":"1544_CR54","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1172\/JCI109824","volume":"66","author":"BA Jackson","year":"1980","unstructured":"Jackson BA, Edwards RM, Valtin H, Dousa TP. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus. J Clin Invest. 1980;66(1):110\u201322.","journal-title":"J Clin Invest"},{"issue":"1 Pt 2","key":"1544_CR55","first-page":"F151","volume":"250","author":"E Kusano","year":"1986","unstructured":"Kusano E, Yusufi AN, Murayama N, Braun-Werness J, Dousa TP. Dynamics of nucleotides in distal nephron of mice with nephrogenic diabetes insipidus. Am J Physiol. 1986;250(1 Pt 2):F151\u20138.","journal-title":"Am J Physiol"},{"issue":"4 Pt 2","key":"1544_CR56","first-page":"F640","volume":"261","author":"AK Coffey","year":"1991","unstructured":"Coffey AK, O\u2019Sullivan DJ, Homma S, Dousa TP, Valtin H. Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus. Am J Physiol. 1991;261(4 Pt 2):F640\u20136.","journal-title":"Am J Physiol"},{"issue":"4","key":"1544_CR57","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000186196","volume":"56","author":"DG Bichet","year":"1990","unstructured":"Bichet DG, Ruel N, Arthus MF, Lonergan M. Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus. Nephron. 1990;56(4):449\u201350.","journal-title":"Nephron"},{"issue":"2","key":"1544_CR58","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2012-1044","volume":"34","author":"HB Moeller","year":"2013","unstructured":"Moeller HB, Rittig S, Fenton RA. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev. 2013;34(2):278\u2013301.","journal-title":"Endocr Rev"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1544-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:14:26Z","timestamp":1660497266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1544-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,24]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1544-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732759718.793555512","asserted-by":"object"}]},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,24]]},"assertion":[{"value":"26 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}